Innate immune regulation in inflammation resolution and liver regeneration in drug-induced liver injury
Archives of Toxicology · 2025
DOI: 10.1007/s00204-024-03886-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archives of Toxicology, 2025. Verfasst von Yihan Qian und 3 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, 528 Zhangheng Road, Shanghai, China. Hauptthemen laut MEDLINE: Liver Regeneration, Immunity, Innate, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 110 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Health Commission, Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Drug-induced liver injury (DILI) is an acute liver injury that poses a significant threat to human health. In severe cases, it can progress into chronic DILI or even lead to liver failure. DILI is typically caused by either intrinsic hepatotoxicity or idiosyncratic metabolic or immune responses. In addition to the direct damage drugs inflict on hepatocytes, the immune responses and liver inflammation triggered by hepatocyte death can further exacerbate DILI. Initially, we briefly discussed the differences in immune cell activation based on the type of liver cell death (hepatocytes, cholangiocytes, and LSECs). We then focused on the role of various immune cells (including macrophages, monocytes, neutrophils, dendritic cells, liver sinusoidal endothelial cells, eosinophils, natural killer cells, and natural killer T cells) in both the liver injury and liver regeneration stages of DILI. This article primarily reviews the role of innate immune regulation mediated by these immune cells in resolving inflammation and promoting liver regeneration during DILI, as well as therapeutic approaches targeting these immune cells for the treatment of DILI. Finally, we discussed the activation and function of liver progenitor cells (LPCs) during APAP-induced massive hepatic necrosis and the involvement of chronic inflammation in DILI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Central Laboratory, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, 528 Zhangheng Road, Shanghai, China.
- Department of Liver Surgery, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
- Shanghai Key Laboratory of Molecular Imaging, Collaborative Innovation Center for Biomedicines, Shanghai University of Medicine and Health Sciences, Shanghai, China. wuhl@sumhs.edu.cn.
- Central Laboratory, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, 528 Zhangheng Road, Shanghai, China. xiaoni-kong@126.com.
ORCID-Profile: Xiaoni Kong
Förderung
- National Natural Science Foundation of China
- Shanghai Municipal Health Commission
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Qian, Y., Zhao, J., Wu, H., & Kong, X. (2025). Innate immune regulation in inflammation resolution and liver regeneration in drug-induced liver injury. Archives of Toxicology. https://doi.org/10.1007/s00204-024-03886-0
Vancouver
Qian Y, Zhao J, Wu H, Kong X. Innate immune regulation in inflammation resolution and liver regeneration in drug-induced liver injury. Archives of Toxicology. 2025. doi:10.1007/s00204-024-03886-0
BibTeX
@article{Qian2025,
author = {Qian, Yihan and Zhao, Jie and Wu, Hailong and Kong, Xiaoni},
title = {Innate immune regulation in inflammation resolution and liver regeneration in drug-induced liver injury},
journal = {Archives of Toxicology},
year = {2025},
doi = {10.1007/s00204-024-03886-0}
}
EUVIMED